Key Points
- CEO Stanley Bergman sold 10,785 shares on Feb. 27 at $81.20 each for $875,742, trimming his stake by 3.37% to 309,092 shares (worth about $25.1M); combined insider sales on Feb. 26–27 totaled roughly $4.0M, which some investors may view as profit‑taking.
- Earnings beat expectations: Henry Schein reported $1.34 EPS vs. $1.30 expected and $3.44B revenue vs. $3.34B expected, with revenue up 7.7% year‑over‑year and FY2026 guidance of $5.230–5.370 EPS.
- Analyst views are mixed: several firms raised price targets (including Robert W. Baird at $100), but the consensus rating is "Hold" with a $85.58 average price target.
Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) CEO Stanley Bergman sold 10,785 shares of the firm's stock in a transaction on Friday, February 27th. The shares were sold at an average price of $81.20, for a total transaction of $875,742.00. Following the transaction, the chief executive officer directly owned 309,092 shares of the company's stock, valued at $25,098,270.40. The trade was a 3.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Henry Schein Price Performance
Henry Schein stock opened at $82.39 on Friday. The stock's 50 day moving average is $77.85 and its 200 day moving average is $72.15. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $89.29. The firm has a market cap of $9.45 billion, a P/E ratio of 25.20, a P/E/G ratio of 2.41 and a beta of 0.88. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.38 and a quick ratio of 0.79.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.04. The firm had revenue of $3.44 billion during the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The company's revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.19 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.
Hedge Funds Weigh In On Henry Schein
A number of institutional investors have recently modified their holdings of HSIC. CYBER HORNET ETFs LLC acquired a new stake in Henry Schein in the 2nd quarter valued at $25,000. MUFG Securities EMEA plc acquired a new position in Henry Schein during the second quarter worth $27,000. Flagship Harbor Advisors LLC acquired a new position in shares of Henry Schein during the fourth quarter valued at about $30,000. Federated Hermes Inc. bought a new stake in shares of Henry Schein during the fourth quarter worth about $32,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Henry Schein in the 4th quarter worth about $37,000. 96.62% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have weighed in on the company. Wells Fargo & Company increased their price target on Henry Schein from $76.00 to $87.00 and gave the stock an "equal weight" rating in a report on Wednesday. Mizuho lifted their target price on Henry Schein from $81.00 to $88.00 and gave the stock a "neutral" rating in a report on Wednesday. Robert W. Baird set a $100.00 price target on Henry Schein and gave the company an "outperform" rating in a research note on Monday. Barrington Research set a $97.00 price objective on shares of Henry Schein and gave the stock an "outperform" rating in a research report on Wednesday. Finally, Evercore boosted their target price on shares of Henry Schein from $83.00 to $90.00 and gave the company an "outperform" rating in a research report on Wednesday, November 5th. Six investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $85.58.
View Our Latest Research Report on HSIC
More Henry Schein News
Here are the key news stories impacting Henry Schein this week:
About Henry Schein
(
Get Free Report)
Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.
In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
